Personalized Diagnostics Reimbursement: Sometimes A Hard Sell
This article was originally published in The Gray Sheet
Executive Summary
Two panelists at the AdvaMed 2007 meeting told different tales of gaining Medicare payment for their assays useful for personalized medicine
You may also be interested in...
AdvaMed Seeks Changes In CMS Payment Process For New Diagnostic Tests
Diagnostics manufacturers are urging CMS to use a more informed and transparent process to set payment rates for innovative tests
Monogram Launches Companion Diagnostic To Pfizer’s New HIV Drug
South San Francisco-based Monogram Biosciences launched its Trofile HIV diagnostic Aug. 6, timed with FDA approval of Pfizer's first-in-class HIV drug Selzentry (maraviroc) the same day
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.